Role of interleukin-17 in defense against pseudomonas aeruginosa infection in lungs

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 4, 2014, Pages 809-816

  Xu, Xilin ^a   Shao, Bing ^b   Wang, Ran ^c   Zhou, Sijing ^d   Tang, Zhongzhi ^a   Lu, Weihua ^a   Xiong, Shengdao ^b  

^a WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

^d Hefei Second People's Hospital   (China)

Author keywords

Gene transfection; Host defense; IL 17; Pneumonia infection; Pseudomonas aeruginosa

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 17; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CLEARANCE; CONTROLLED STUDY; ENZYME ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; HOST RESISTANCE; LUNG LAVAGE; MALE; MOUSE; MRNA EXPRESSION ASSAY; NEUTROPHIL COUNT; NONHUMAN; PSEUDOMONAS INFECTION; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION MAPPING;

EID: 84900452685     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Rello J and Diaz E. Pneumonia in the intensive care unit. Crit Care Med 2003; 31: 2544-2551.
2. Chastre J and Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165: 867-903.
3. Chastre J and Trouillet JL. Problem pathogens (Pseudomonas aeruginosa and Acinetobacter). Semin Respir Infect 2000; 15: 287-298.
4. Afessa B and Green B. Bacterial pneumonia in hospitalized patients with HIV infection: the Pulmonary Complications, ICU Support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study. Chest 2000; 117: 1017-1022.
5. Talbot GH, Bradley J, Edwards JE Jr, Gilbert D, Scheld M and Bartlett JG. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 2006; 42: 657-668.
6. Sadikot RT, Blackwell TS, Christman JW and Prince AS. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med 2005; 171: 1209-1223.
7. Hoshino H, Laan M, Sjostrand M, Lotvall J, Skoogh BE and Linden A. Increased elastase and myeloperoxidase activity associated with neutrophil recruitment by IL-17 in airways in vivo. J Allergy Clin Immunol 2000; 105: 143-149.
8. Semik-Orzech A, Barczyk A and Pierzchala W. [The role of interleukin 17A in inducing neutrophilic inflammation in the pulmonary tract]. Pol Merkur Lekarski 2007; 22: 163-168.
9. Linden A, Laan M and Anderson GP. Neutrophils, interleukin-17A and lung disease. Eur Respir J 2005; 25: 159-172.
10. Shellito JE, quan Zheng M, Ye P, Ruan S, Shean MK and Kolls J. Effect of alcohol consumption on host release of interleukin-17 during pulmonary infection with Klebsiella pneumoniae. Alcohol Clin Exp Res 2001; 25: 872-881.
11. Gaffen SL. An overview of IL-17 function and signaling. Cytokine 2008; 43: 402-407.
12. Hellings PW, Kasran A, Liu Z, Vandekerckhove P, Wuyts A, Overbergh L, Mathieu C and Ceuppens JL. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Respir Cell Mol Biol 2003; 28: 42-50.
13. Barczyk A, Pierzchala W and Sozanska E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med 2003; 97: 726-733.
14. Molet S, Hamid Q, Davoine F, Nutku E, Taha R, Page N, Olivenstein R, Elias J and Chakir J. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001; 108: 430-438.
15. Laan M, Lotvall J, Chung KF and Linden A. IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases. Br J Pharmacol 2001; 133: 200-206.
16. Moraes TJ, Martin R, Plumb JD, Vachon E, Cameron CM, Danesh A, Kelvin DJ, Ruf W and Downey GP. Role of PAR2 in murine pulmonary pseudomonal infection. Am J Physiol Lung Cell Mol Physiol 2008; 294: L368-377.
17. Morris AE, Liggitt HD, Hawn TR and Skerrett SJ. Role of Toll-like receptor 5 in the innate immune response to acute P. aeruginosa pneumonia. Am J Physiol Lung Cell Mol Physiol 2009; 297: L1112-1119.
18. Hu Q, Zuo P, Shao B, Yang S, Xu G, Lan F, Lu X, Xiong W, Xu Y and Xiong S. Administration of nonviral gene vector encoding rat beta-defensin-2 ameliorates chronic Pseudomonas aeruginosa lung infection in rats. J Gene Med 2010; 12: 276-286.
19. Parkins MD, Gregson DB, Pitout JD, Ross T and Laupland KB. Population-based study of the epidemiology and the risk factors for Pseudomonas aeruginosa bloodstream infection. Infection 2010; 38: 25-32.
20. Girou E, Schortgen F, Delclaux C, Brun-Buisson C, Blot F, Lefort Y, Lemaire F and Brochard L. Association of noninvasive ventilation with nosocomial infections and survival in critically ill patients. JAMA 2000; 284: 2361-2367.
21. Kolls JK and Linden A. Interleukin-17 family members and inflammation. Immunity 2004; 21: 467-476.
22. Li H, Chen J, Huang A, Stinson J, Heldens S, Foster J, Dowd P, Gurney AL and Wood WI. Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc Natl Acad Sci U S A 2000; 97: 773-778.
23. Shi Y, Ullrich SJ, Zhang J, Connolly K, Grzegorzewski KJ, Barber MC, Wang W, Wathen K, Hodge V, Fisher CL, Olsen H, Ruben SM, Knyazev I, Cho YH, Kao V, Wilkinson KA, Carrell JA and Ebner R. A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity. J Biol Chem 2000; 275: 19167-19176.
24. Hymowitz SG, Filvaroff EH, Yin JP, Lee J, Cai L, Risser P, Maruoka M, Mao W, Foster J, Kelley RF, Pan G, Gurney AL, de Vos AM and Starovasnik MA. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J 2001; 20: 5332-5341.
25. Moseley TA, Haudenschild DR, Rose L and Reddi AH. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 2003; 14: 155-174.
26. Wagner JG and Roth RA. Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol Rev 2000; 52: 349-374.
27. Jones CE and Chan K. Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells. Am J Respir Cell Mol Biol 2002; 26: 748-753.
28. Laan M, Cui ZH, Hoshino H, Lotvall J, Sjostrand M, Gruenert DC, Skoogh BE and Linden A. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 1999; 162: 2347-2352.
29. Ivanov S and Linden A. Th-17 cells in the lungs? Expert Rev Respir Med 2007; 1: 279-293.
30. Miyamoto M, Prause O, Sjostrand M, Laan M, Lotvall J and Linden A. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol 2003; 170: 4665-4672.
31. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, Oliver P, Huang W, Zhang P, Zhang J, Shellito JE, Bagby GJ, Nelson S, Charrier K, Peschon JJ and Kolls JK. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001; 194: 519-527.
32. Wilson KR, Napper JM, Denvir J, Sollars VE and Yu HD. Defect in early lung defence against Pseudomonas aeruginosa in DBA/2 mice is associated with acute inflammatory lung injury and reduced bactericidal activity in naive macrophages. Microbiology 2007; 153: 968-979.
33. Dubin PJ and Kolls JK. IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice. Am J Physiol Lung Cell Mol Physiol 2007; 292: L519-528.
34. Ferretti S, Bonneau O, Dubois GR, Jones CE and Trifilieff A. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol 2003; 170: 2106-2112.
35. Reiniger N, Lee MM, Coleman FT, Ray C, Golan DE and Pier GB. Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor. Infect Immun 2007; 75: 1598-1608.
36. Ye P, Garvey PB, Zhang P, Nelson S, Bagby G, Summer WR, Schwarzenberger P, Shellito JE and Kolls JK. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am J Respir Cell Mol Biol 2001; 25: 335-340.